AI in Healthcare: Insights from Two Decades of FDA Approvals

Oct 06, 2021

Posted by Health Advances LLC

Resurgence in Drug Development for Renal Diseases

Oct 06, 2021

Posted by Health Advances LLC

Japan and China are Outpacing Europe as Leading Biopharmaceutical Innovation Hubs

Oct 06, 2021

Posted by Health Advances LLC

Unlocking Potential Cures with CRISPR: Indication Selection And Portfolio Strategy For CRISPR-Based Gene Editing Companies

Oct 06, 2021

Posted by Health Advances LLC

The work anywhere paradox

Sep 15, 2021

Posted by Heidrick & Struggles

“Why Don’t Stem-gene Cell Clinical Trial Sponsors Count Their Stem Cells?”

Aug 25, 2021

The search for a better charge model

Aug 04, 2021

Posted by Cresset

Flare™ FEP: Competitively combining speed and accuracy with ease of use

Jul 27, 2021

Posted by Cresset

Regulatory Oversight in Gene Therapy: How Far Have We Come?

Jul 23, 2021